CCP
ITCI
Clough Capital Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,400
| Closed | -$449K | – | 135 |
|
|
2025
Q1 | $449K | Hold |
3,400
| – | – | 0.06% | 99 |
|
|
2024
Q4 | $284K | Hold |
3,400
| – | – | 0.03% | 116 |
|
|
2024
Q3 | $249K | Hold |
3,400
| – | – | 0.03% | 129 |
|
|
2024
Q2 | $233K | Buy |
+3,400
| New | +$233K | 0.03% | 118 |
|
|
2019
Q2 | – | Sell |
-133,224
| Closed | -$1.62M | – | 136 |
|
|
2019
Q1 | $1.62M | Sell |
133,224
-1,200
| -0.9% | -$14.6K | 0.14% | 85 |
|
|
2018
Q4 | $1.53M | Sell |
134,424
-367,200
| -73% | -$4.18M | 0.18% | 89 |
|
|
2018
Q3 | $10.9M | Sell |
501,624
-69,000
| -12% | -$1.5M | 1.03% | 28 |
|
|
2018
Q2 | $10.1M | Buy |
570,624
+71,000
| +14% | +$1.25M | 0.9% | 39 |
|
|
2018
Q1 | $10.5M | Sell |
499,624
-200,326
| -29% | -$4.22M | 1.01% | 34 |
|
|
2017
Q4 | $10.1M | Buy |
699,950
+41,200
| +6% | +$597K | 0.84% | 41 |
|
|
2017
Q3 | $10.4M | Buy |
658,750
+281,900
| +75% | +$4.45M | 0.7% | 45 |
|
|
2017
Q2 | $4.68M | Sell |
376,850
-521,900
| -58% | -$6.48M | 0.32% | 70 |
|
|
2017
Q1 | $14.6M | Buy |
898,750
+549,100
| +157% | +$8.92M | 0.93% | 34 |
|
|
2016
Q4 | $5.28M | Buy |
349,650
+177,800
| +103% | +$2.68M | 0.35% | 79 |
|
|
2016
Q3 | $2.62M | Sell |
171,850
-53,800
| -24% | -$820K | 0.14% | 118 |
|
|
2016
Q2 | $8.76M | Buy |
225,650
+25,600
| +13% | +$994K | 0.47% | 71 |
|
|
2016
Q1 | $5.56M | Sell |
200,050
-8,550
| -4% | -$238K | 0.26% | 102 |
|
|
2015
Q4 | $11.2M | Sell |
208,600
-70,400
| -25% | -$3.79M | 0.52% | 67 |
|
|
2015
Q3 | $11.2M | Buy |
279,000
+57,200
| +26% | +$2.29M | 0.48% | 66 |
|
|
2015
Q2 | $7.09M | Sell |
221,800
-3,200
| -1% | -$102K | 0.27% | 98 |
|
|
2015
Q1 | $5.37M | Buy |
+225,000
| New | +$5.37M | 0.18% | 128 |
|